---
{"dg-publish":true,"permalink":"/USMLE/Psychiatry/Antipsychotics/","tags":["t2"]}
---

>[!Mnemonic] 
>Antipsychotics are thought to work by blocking the <font color="#ffc000">D2</font> receptor.
>Psychotic patients sometimes take a <font color="#ffc000">DetouR</font> from reality.![Pasted image 20240315135310.png](/img/user/appendix/Pasted%20image%2020240315135310.png)


- First-generation antipsychotics (also called typical antipsychotics): block D2 receptor → ↑ cAMP
	- High-potency antipsychotics have a strong antipsychotic effect even at relatively low doses, but they also more commonly cause neurologic side effects (e.g., extrapyramidal symptoms) than low-potency antipsychotics.
		- <span style="background:rgba(240, 200, 0, 0.2)">Haloperidol</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Fluphenazine</span>
		- Perphenazine
		- Trifluoperazine
		- Pimozide
	- Low-potency antipsychotics more commonly cause anticholinergic, [[USMLE/Immunology/Antihistamines\|antihistamine]], and sympathetic α1-blockade effects.
		- <span style="background:rgba(240, 200, 0, 0.2)">Chlorpromazine</span>
		- Thioridazine
	- Stored in fat tissue (lipid soluble) and, therefore, only slowly eliminated from the body.
- <span style="background:rgba(240, 200, 0, 0.2)">Second-generation antipsychotics (also called atypical antipsychotics): most are 5-HT2 and D2 antagonists with varying α and H1 receptor effects</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Serotonin antagonism can help modulate dopamine, reducing its EPS side effect.</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Also can improved negative and cognitive symptoms</span>

>[!tip] 
><span style="background:rgba(240, 200, 0, 0.2)">Antipsychotics block dopamine receptor, instead of inhibiting dopamine reuptake, as seen in antidepressants.</span>

# First-generation antipsychotics (FGAs)
## High-potency
### Haloperidol
- Brand name: <span style="background:rgba(240, 200, 0, 0.2)">Haldol</span>
- High-potency antipsychotics
	- [[USMLE/Neurology/Neurotransmitters\|Dopamine]]-specific antagonism (D2 receptor)
- Extrapyramidal symptoms most common in high-potency FGAs
	- <font color="#ffc000">HOLD</font>-ol![Pasted image 20240315150139.png](/img/user/appendix/Pasted%20image%2020240315150139.png)
### Adverse effects
- [[USMLE/Endocrine/Hyperprolactinemia\|Hyperprolactinemia]] 
	- Dopamine inhibits the release of prolactin via the D2 receptor in the [[USMLE/Neurology/Dopaminergic pathway\|tuberoinfundibular pathway]]. Therefore, dopamine antagonists increase the effects of prolactin.
- <span style="background:rgba(240, 200, 0, 0.2)">Extrapyramidal symptoms most common in high-potency FGAs</span>
- Prolonged QT interval
- [[USMLE/Psychiatry/Neuroleptic malignant syndrome\|Neuroleptic malignant syndrome]]
## Low-potency
### Chlorpromazine
- Low-potency antipsychotics
	- [[USMLE/Neurology/Neurotransmitters\|Dopamine]] antagonism
	- Anticholinergic
	- Antihistaminergic
- First discovered, wide range of indications
- Corneal deposits
>[!Mnemonic] 
>氯丙嗪，治精神；阻断多巴Ma不灵。止吐冬眠和降温，就是不治晕动病。不良反应帕金森，张口伸舌坐不能。口干好似阿托品，乳汁分泌羞死人。

>[!Mnemonic] 
><font color="#ffc000">Chlor</font>-neal deposits
### Adverse effects
- Anticholinergic effects, sympatholytic effects, metabolic effects, and <span style="background:rgba(240, 200, 0, 0.2)">sedation dominate</span>
	- Sedation due to histamine receptor blockade, see [[USMLE/Immunology/Antihistamines\|Antihistamines]]

>[!Mnemonic] Difference of Adverse Effects
>Low-potency antipsychotics require higher doses to achieve the desired effect, which leads to more prominent blockage of other receptors except D2.
# Second-generation antipsychotics (SGAs)
## Clozapine
- <span style="background:rgba(240, 200, 0, 0.2)">Most effective antipsychotic</span>
- Indications
	- <span style="background:rgba(240, 200, 0, 0.2)">Treatment-resistant [[USMLE/Psychiatry/Schizophrenia\|schizophrenia]]</span>
	- [[USMLE/Psychiatry/Schizophrenia\|Schizophrenia]] associated with <span style="background:rgba(240, 200, 0, 0.2)">suicidality</span>
- Clozapine can cause agranulocytosis and lowers the seizure threshold
>[!Mnemonic] 
>You must watch <font color="#ffc000">cloz</font>apine <font color="#ffc000">cloz</font>ely to monitor for agranulocytosis!![Pasted image 20240315151042.png](/img/user/appendix/Pasted%20image%2020240315151042.png)
## Olanzapine
- Second effective antipsychotic, without risk of agranulocytosis
- <span style="background:rgba(240, 200, 0, 0.2)">Metabolic effects (usually weight gain</span>, hyperglycemia, new-onset [[USMLE/Endocrine/Diabetes mellitus\|diabetes mellitus]], dyslipidemia) most prominent
>[!Mnemonic] 
>Olanzapine can make patients <span style="background:rgba(240, 200, 0, 0.2)">gain weight</span>, so it's the pharmacological choice for [[USMLE/Psychiatry/Anorexia nervosa\|Anorexia nervosa]]![Pasted image 20240315151300.png](/img/user/appendix/Pasted%20image%2020240315151300.png)
## Risperidone
- Less sedation, good for elderly patients
>[!Mnemonic] 
><font color="#ffc000">Ris</font>e and shine
## Quetiapine
- More sedation
>[!Mnemonic] 
><font color="#ffc000">Quiet</font>iapine
# Adverse effects
>[!tip] Summary
>- **Extrapyramidal side effects:**
>    - Acute dystonic reaction: sudden-onset, sustained muscle contractions
>    - Akathisia: subjective restlessness with inability to sit still
>    - Drug-induced parkinsonism: tremor, rigidity, bradykinesia, masked facies
>- **Tardive dyskinesia:**
>    - Involuntary movements after chronic use (e.g., lip smacking, choreoathetoid movements)
>- **Neuroleptic malignant syndrome:**
>    - Fever, rigidity, mental status changes, autonomic instability


- First-generation antipsychotics (FGAs)
	- High-potency (eg, haloperidol)
		- <span style="background:rgba(240, 200, 0, 0.2)">Extrapyramidal symptoms (acute dystonia, akathisia, parkinsonism), tardive dyskinesia</span>
	- Low-potency (eg, chlorpromazine)
		- <span style="background:rgba(240, 200, 0, 0.2)">Sedation, cholinergic blockade, orthostatic hypotension</span>, weight gain
- Second-generation antipsychotics (SGAs)
	- <span style="background:rgba(240, 200, 0, 0.2)">Metabolic syndrome, weight gain</span>
	- Extrapyramidal symptoms (less common than FGAs)
## [[USMLE/Endocrine/Hyperprolactinemia\|Hyperprolactinemia]]
- Elevated prolactin levels: Dopamine inhibits the release of prolactin via the D2 receptor in the tuberoinfundibular pathway. Therefore, <span style="background:rgba(240, 200, 0, 0.2)">dopamine antagonists increase the effects of prolactin</span>.![L26372.jpg](/img/user/appendix/L26372.jpg)
- <span style="background:rgba(240, 200, 0, 0.2)">↑ Prolactin → suppression of GnRH → ↓ LH, ↓ FSH → ↓ [[USMLE/Reproductive/Androgen and estrogen synthesis\|estrogen]], ↓ testosterone → hypogonadotropic hypogonadism</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Most common in risperidone, amisulpride</span>
- In men: gynecomastia, galactorrhea, hypogonadotropic hypogonadism (erectile dysfunction, reduced libido, infertility)
- In women: galactorrhea, oligomenorrhea, hypogonadotropic hypogonadism (<span style="background:rgba(240, 200, 0, 0.2)">amenorrhea</span>, reduced libido, infertility)

>[!Mnemonic] 
><font color="#ffc000">RISE-PAIR</font>-idone gives <font color="#ffc000">RISE</font> to a <font color="#ffc000">PAIR</font>![Pasted image 20240315143057.png](/img/user/appendix/Pasted%20image%2020240315143057.png)
## Extrapyramidal symptoms (EPS)
- Pathophysiology: Inhibition of the nigrostriatal dopaminergic pathways results in EPS.
	- First-generation high-potency antipsychotics: D2 antagonism → EPS
	- Second-generation antipsychotics: weaker D2 antagonism → fewer EPS
- Clinical features similar to [[USMLE/Neurology/Parkinson disease\|Parkinson disease]]: Muscle, rustle, and hustle![Pasted image 20240317222923.png](/img/user/appendix/Pasted%20image%2020240317222923.png)
	- Acute dystonia
		- Onset: <span style="background:rgba(240, 200, 0, 0.2)">Hours to days</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Painful and lasting muscle spasms and stiffness predominantly affecting the head, neck, and tongue</span> 
		- <span style="background:rgba(240, 200, 0, 0.2)">Facial grimacing, torticollis</span>
		- Tongue protrusion or twisting
		- Oculogyric crisis (upward deviation of the eyes)
		- In severe cases: laryngospasm, opisthotonus of the back
	- Pseudoparkinsonism
		- Onset: ∼ 1–4 weeks
	- Akathisia
		- 1–8 weeks
		- <span style="background:rgba(240, 200, 0, 0.2)">Restlessness/compelling urge to move</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Inability to sit or stand still</span>
		- See [[USMLE/Neurology/Restless legs syndrome\|Restless legs syndrome]]
	- Tardive dyskinesia
		- Months to years
		- Repetitive chewing and lip smacking
		- Choreic movements
		- <span style="background:rgba(240, 200, 0, 0.2)">Can be irreversible if drug is not discontinued</span>
- Treatment
	- Decrease or discontinue offending medication
	- <span style="background:rgba(240, 200, 0, 0.2)">Anticholinergics (trihexyphenidyl, benztropine)</span>

>[!Mnemonic] 
><span style="background:rgba(240, 200, 0, 0.2)">Chewing Tar</span>dive![32wab_.gif](/img/user/appendix/32wab_.gif)
## 
<div class="transclusion internal-embed is-loaded"><a class="markdown-embed-link" href="/USMLE/Psychiatry/Neuroleptic malignant syndrome/" aria-label="Open link"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-link"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a><div class="markdown-embed">




# Epidemiology
---


# Etiology
---
- <span style="background:rgba(240, 200, 0, 0.2)">High-potency first-generation [[USMLE/Psychiatry/Antipsychotics\|antipsychotics]] (most common association)</span>
- Second-generation [[USMLE/Psychiatry/Antipsychotics\|antipsychotics]]
- Other [[USMLE/Neurology/Neurotransmitters\|dopamine]] antagonists, e.g., [[USMLE/GI/Antiemetics\|metoclopramide]], promethazine

# Pathophysiology
---
- <span style="background:rgba(240, 200, 0, 0.2)">Central D2 receptor blockade in the [[USMLE/Neurology/Dopaminergic pathway\|nigrostriatal pathway]] and [[USMLE/Neurology/Hypothalamus\|hypothalamus]], resulting in movement disorders and impaired thermoregulation</span>

# Clinical features
---
- <span style="background:rgba(240, 200, 0, 0.2)">Mental status changes (encephalopathy)</span>
	- [[USMLE/Psychiatry/Delirium\|Delirium]] (e.g., reduced vigilance)
	- Confusion
	- Stupor
	- Catatonia
- <span style="background:rgba(240, 200, 0, 0.2)">Parkinsonism</span>
	- Muscle [[USMLE/MSK/Spasticity (Clonus) vs Rigidity\|rigidity]] (lead-pipe [[USMLE/MSK/Spasticity (Clonus) vs Rigidity\|rigidity]])
	- Akinesia
	- [[USMLE/Neurology/Tremor\|Tremor]]
- <span style="background:rgba(240, 200, 0, 0.2)">Hyperthermia: High-grade fever is common.</span>
	- Because muscles working overtime
- <span style="background:rgba(240, 200, 0, 0.2)">Autonomic instability</span>
	- Tachycardia, dysrhythmias, labile blood pressure
	- Tachypnea
	- Diaphoresis

# Diagnostics
---
Clinical features similar to [[USMLE/Neurology/Serotonin syndrome\|Serotonin syndrome]]

|                       | Neuroleptic malignant syndrome               | Serotonin syndrome                          |
|-----------------------|---------------------------------------------|---------------------------------------------|
| **Precipitant**       | Dopamine antagonist                         | Serotonergic agent                          |
| **Onset**             | 1-3 days                                    | <1 day                                      |
| **Altered mental status** | Yes                                    | Yes                                         |
| **Sympathetic hyperactivity** | Yes                                  | Yes                                         |
| **Diffuse rigidity**  | "Lead-pipe" rigidity                       | No                                          |
| **Clonus**            | No                                          | Yes                                         |
| **Reflexes**          | Hyporeflexia                                | Hyperreflexia                               |

>[!tip] 
>- **Neurotransmitter Specificity**:
>	- **Dopamine Blockade in NMS**:
> 		   - <span style="background:rgba(240, 200, 0, 0.2)">Dopamine is crucial for inhibiting overactivity in muscle movements</span>. Its blockade removes this inhibition, causing muscles to become rigid.
> 		   - The <span style="background:rgba(240, 200, 0, 0.2)">lack of dopamine dampens reflex arcs, leading to hyporeflexia.</span>
>	- **Serotonin Excess in Serotonin Syndrome**:
> 		   - <span style="background:rgba(240, 200, 0, 0.2)">Serotonin enhances excitatory signals</span> in the nervous system.
> 		   - <span style="background:rgba(240, 200, 0, 0.2)">Increased serotonin amplifies reflex pathways, resulting in hyperreflexia and clonus.</span>
>- **Neuromuscular Impact**:
>	- The **balance between inhibitory and excitatory neurotransmitters** is essential for normal muscle function.
>	- NMS tips the scale towards **inhibition loss** (due to dopamine blockade), causing rigidity.
>	- Serotonin syndrome tips the scale towards **excess excitation**, leading to clonus and hyperactive reflexes.

# Treatment
---
- <span style="background:rgba(240, 200, 0, 0.2)">Discontinue suspected causative agent (e.g., [[USMLE/Psychiatry/Antipsychotics\|antipsychotics]]).</span>
- Pharmacotherapy 
	- <span style="background:rgba(240, 200, 0, 0.2)">Skeletal muscle relaxant: Dantrolene (See [[USMLE/Neurology/Malignant hyperthermia#Treatment\|Malignant hyperthermia#Treatment]])</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Dopamine agonists, e.g., bromocriptine, amantadine</span>, or apomorphine
	- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Psychiatry/Sedative-hypnotic drugs\|Benzodiazepines]]</span>, e.g., lorazepam: can be used to treat mild symptoms of NMS and/or psychomotor agitation
	- Calcium-channel blockers: for hypertension


</div></div>

